Skip to main content

GASTROINTESTINAL CANCER PROGRAM


Advanced Diagnostics and Therapeutics

  • Biomarker, Molecular, Genetic Testing
  • Expertise in minimally invasive and robotic surgery
  • Cutting-Edge Clinical Trials for GI Cancer Patients
  • Hyperthermic Intraperitoneal Chemotherapy(HIPEC)
  • Hepatic Artery Infusion Pump (HAIP)
  • Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR), Tumor Ablation, Endoscopic Gastrojejunostomy
  • Lutathera® for Neuroendocrine Tumors

Comprehensive Care That Empowers Patients Through Risk Management, Prevention, Detection, Treatment, and Survivorship Services

Where your patient starts their cancer journey matters.
Behind every gastrointestinal (GI) cancer patient at Fox Chase Cancer Center is a multidisciplinary team of highly experienced and trained specialists who provide compassionate care and ensure the best possible outcomes with the fewest side effects.

  • Individualized treatment plans based on your patient’s unique genetic and biological profiles and family and clinical histories, with access to genetic counselors, and high-risk follow-up with our multidisciplinary team.
  • Early GI cancer screening, detection, diagnosis, and prevention through a robust gastroenterology program.
  • Our multidisciplinary team includes surgical, radiation, and medical oncologists, along with gastroenterologists, radiologists, pathologists, anesthesiologists, advanced practice providers, and specialized oncologic nurses.
  • Throughout treatment, referring physicians are kept informed about your patient’s care and progress.

Innovative Treatment Strategies for All Stages of Common and Rare Gastrointestinal Cancers

  • Offering innovative treatment options for early-stage and late-stage gastrointestinal (GI) cancers of the rectum, colon, anus, small intestine, pancreas, liver, stomach, esophagus, bile ducts, and gallbladder.
  • Our gastroenterologists offer expertise in endoscopic submucosal dissection (ESD), endoscopic full thickness resection (EFTR), radiofrequency ablation (RFA), hybrid argon plasma coagulation (APC), and cryotherapy for precancerous conditions.
  • Fox Chase’s highly trained surgical oncologists offer specific skill and expertise in minimally invasive and robotic surgery.
  • Biomarker-driven personalized systemic treatments and cutting-edge clinical trials for GI cancer patients.
  • National leaders in cutting edge radiation techniques such as CT-based adaptive radiation.
  • Highly skilled in Hepatic Artery Infusion Pump (HAIP): targeted therapy that shrinks colon cancer tumors that have metastasized to the liver so surgery can be performed.
  • One of a few Philadelphia-region hospitals offering hyperthermic intraperitoneal chemotherapy (HIPEC)—delivering chemotherapy directly to the lining of the abdominal cavity during surgery.
  • Among the first to offer Lutathera, a first-line FDAapproved therapy for neuroendocrine tumors.
  • Our high-volume pancreatic cyst clinic offers individually tailored treatment and surveillance strategies for all types of pancreatic lesions.
  • Through the Marvin and Concetta Greenberg Pancreatic Cancer Institute, integration of our clinical team and basic scientists results in breakthrough investigator-initiated translational studies for patients


Devotion and Perseverance in GI Cancer Clinical Trials

    Fox Chase physicians offer a robust portfolio of GI cancer clinical trials, many of which are only available at our Center. For all our clinical trials or visit FoxChase.org/ClinicalTrials.


Supportive Services from Day One

  • Before a first appointment, your patient receives a timely phone call from a GI Nurse Navigator who offers complete, coordinated care with education, scheduling, and testing and listens compassionately to patient questions and concerns.
  • Specialty supportive oncology is appropriate when extra care is needed at any stage of cancer.
  • After treatment, the Fox Chase Survivorship Program helps patients safeguard their health and well-being for a lifetime.

Why Choose Fox Chase?

  • Fox Chase is a National Cancer Institute (NCI) Comprehensive Cancer Center: the highest NCI designation for excellence in cancer treatment, research, prevention, and education.
  • Nationally ranked among the nation’s top 50 hospitals for cancer care by U.S. News and World Report.
  • Fox Chase is distinguished regionally as a founding member of the National Comprehensive Cancer Network® (NCCN), a not-for-profit alliance of leading cancer centers. Our faculty members participate in cancer panels at the NCCN, helping to write the guidelines for cancer care that inform clinical decisions in medical centers across the country.
  • Fox Chase is the only institution in the Philadelphia region to earn the National Pancreas Foundation designation.
  • Nationally recognized GI specialists are consistently rated by Philadelphia Magazine as Top Doctors®.

Contact Our Team
Our Key Account Managers can offer a seamless introduction to our specialists, obtain a patient appointment, and answer any questions or concerns you have. Contact our team at KeyAccountManager@fccc.edu.

Fox Chase Cancer Center Breast Cancer Locations
• Fox Chase Cancer Center – Main Campus
• Fox Chase Cancer Center – Buckingham
• Fox Chase Cancer Center – Chestnut Hill
• Fox Chase Cancer Center – East Norriton
• Fox Chase Cancer Center – Voorhees
• Fox Chase Cancer Center at Temple University Hospital – Main Campus